PI3K pathway as a major determinant of resistance to HER2-targeted therapy in advanced gastric cancer

被引：0
|
作者：
Kim, Hyo Song
Zhang, Xianglan
Park, Kyu Hyun
Park, Ji Soo
Kim, Ki Hyang
Chung, Hyun Cheol
Rha, Sun Young
机构：
[1] Yonsei Univ Coll Med, Dept Internal Med, Seoul, South Korea
[2] Yonsei Univ Coll Dent, Oral Canc Res Inst, Seoul, South Korea
[3] Yonsei Univ Coll Med, Canc Metastasis Res Ctr, Seoul, South Korea
[4] Yonsei Univ Coll Med, Div Med Oncol, Dept Internal Med, Yonsei Canc Ctr, Seoul, South Korea
[5] Inje Univ Coll Med, Busan Paik Hosp, Div Hematol Oncol, Dept Internal Med, Pusan, South Korea
[6] Yonsei Univ Heath Syst, Yonsei Canc Ctr, Seoul, South Korea
[7] Yonsei Univ Coll Med, Yonsei Canc Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4089
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Potential of overcoming resistance to HER2-targeted therapies through the PI3K/Akt/mTOR pathway
    Wilks, Sharon T.
    BREAST, 2015, 24 (05): : 548 - 555
  • [2] History and Future of HER2-Targeted Therapy for Advanced Gastric Cancer
    Ariga, Shin
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (10)
  • [3] The Role of the PI3K/AKT, RAS/MAPK and Novel Signaling Pathways in Resistance to HER2-Targeted Therapy
    O'Brien, N. A.
    Wilcox, K.
    McDermott, M.
    Crown, J.
    O'Donovan, N.
    Slamon, D. J.
    CANCER RESEARCH, 2010, 70
  • [4] Targeting PI3K/mTOR Overcomes Resistance to HER2-Targeted Therapy Independent of Feedback Activation of AKT
    O'Brien, Neil A.
    McDonald, Karen
    Tong, Luo
    von Euw, Erika
    Kalous, Ondrej
    Conklin, Dylan
    Hurvitz, Sara A.
    di Tomaso, Emmanuelle
    Schnell, Christian
    Linnartz, Ronald
    Finn, Richard S.
    Hirawat, Samit
    Slamon, Dennis J.
    CLINICAL CANCER RESEARCH, 2014, 20 (13) : 3507 - 3520
  • [5] PTEN Deficiency as a Predictive Biomarker of Resistance to HER2-Targeted Therapy in Advanced Gastric Cancer
    Zhang, Xianglan
    Park, Ji Soo
    Park, Kyu Hyun
    Kim, Ki Hyang
    Jung, Minkyu
    Chung, Hyun Cheol
    Rha, Sun Young
    Kim, Hyo Song
    ONCOLOGY, 2015, 88 (02) : 76 - 85
  • [6] Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer
    Mezynski, M. Janusz
    Farrelly, Angela M.
    Cremona, Mattia
    Carr, Aoife
    Morgan, Clare
    Workman, Julie
    Armstrong, Paul
    McAuley, Jennifer
    Madden, Stephen
    Fay, Joanna
    Sheehan, Katherine M.
    Kay, Elaine W.
    Holohan, Ciara
    Elamin, Yasir
    Rafee, Shereen
    Morris, Patrick G.
    Breathnach, Oscar
    Grogan, Liam
    Hennessy, Bryan T.
    Toomey, Sinead
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [7] Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer
    M. Janusz Mezynski
    Angela M. Farrelly
    Mattia Cremona
    Aoife Carr
    Clare Morgan
    Julie Workman
    Paul Armstrong
    Jennifer McAuley
    Stephen Madden
    Joanna Fay
    Katherine M. Sheehan
    Elaine W. Kay
    Ciara Holohan
    Yasir Elamin
    Shereen Rafee
    Patrick G. Morris
    Oscar Breathnach
    Liam Grogan
    Bryan T. Hennessy
    Sinead Toomey
    Journal of Translational Medicine, 19
  • [8] Targeting the PI3K pathway in HER2-positive gastric cancer
    Toomey, S.
    Farrelly, A. M.
    Mezynski, M. J.
    Carr, A.
    Armstrong, P.
    Mcauley, J.
    Fay, J.
    Kay, E. W.
    Cremona, M.
    Holohan, C.
    Keegan, N. M.
    Elamin, Y.
    Rafee, S.
    Hennessy, B. T.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E142 - E142
  • [9] Inhibition of the PI3K pathway in HER2-positive gastric cancer
    Toomey, S.
    Mezynski, M. J.
    Farrelly, A.
    Armstrong, P.
    McAuley, J.
    Holohan, C.
    Elamin, Y. Y.
    Rafee, S.
    Workman, J.
    Cremona, M.
    Grogan, L.
    Breathnach, O. S.
    Morris, P. G.
    Fay, J.
    Kay, E.
    Hennessy, B. T.
    ANNALS OF ONCOLOGY, 2019, 30
  • [10] Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway
    Morgan, Todd M.
    Koreckij, Theodore D.
    Corey, Eva
    CURRENT CANCER DRUG TARGETS, 2009, 9 (02) : 237 - 249
12345